ArticleBMJ (Clinical research ed.)2017
Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.
Article in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 30 citations in OpenAlex.
- Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.Journal of dual diagnosisTrial
- A missed opportunity: receipt of medication for opioid use disorder in Southern California acute care settings.Addiction science & clinical practice · 2026Article
- Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026Article
- Article
- Emergency department management of opioid use disorder in pediatric patients.Journal of the American College of Emergency Physicians open · 2024Article
- Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.Addiction science & clinical practice · 2022Article
- Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.Addiction (Abingdon, England) · 2021Article
- Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.Contemporary clinical trials · 2021Article
- Article
- Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.BMJ (Clinical research ed.) · 2020Article
- Targeting opioid dysregulation in depression for the development of novel therapeutics.Pharmacology & therapeutics · 2019Review
- Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs.American journal of public health · 2019Article
- Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose.Journal of urban health : bulletin of the New York Academy of Medicine · 2019Article
- Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.Drug and alcohol dependence · 2018Article
- Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions.Frontiers in psychiatry · 2018Article
Corrections and comments
- Comment on
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.